Groups: Board of Directors

Garry Nolan, PhD

Garry co-founded Akoya Biosciences in 2015, and is the Rachford and Carlota A. Harris Professor in the Department of Pathology at Stanford University School of Medicine. As a co-inventor of the CODEX technology, Garry has focused his research efforts on developing novel technologies and computational methods for research into cancer, leukemia, immunology and autoimmune disease. …

Garry Nolan, PhD Read More »

Matthew Winkler, Ph.D.

Dr. Winkler has served on our board of directors since July 2017. Dr. Winkler is the former Chairman and founder of Asuragen.  Asuragen was sold in 2021 to Bio-Techne. He also founded Mirna Therapeutics(MIRN) (merged with Synlogic 2017) and Ambion, Inc. Ambion was acquired in 2006 by Applied Biosystems, now Thermo Fisher Scientific. Dr. Winkler …

Matthew Winkler, Ph.D. Read More »

Thomas Raffin, MD

Tom has served on the Akoya Board of Directors since the inception of Akoya Biosciences. Tom spent 24 years on the faculty at Stanford University School of Medicine where he remains the Colleen and Robert Haas Professor Emeritus of Medicine and Biomedical Ethics, former Chief of Pulmonary and Critical Care Medicine, and Co-Founder and Director …

Thomas Raffin, MD Read More »

Robert Shepler

Bob has served on Akoya Bioscience’s board since the company’s inception in 2015.  Bob was a founder and served as a Managing Director of Telegraph Hill Partners (THP), a growth equity/late-stage venture capital investment firm focused exclusively on healthcare related companies, since its founding in 2001 until August 2020 when he became Partner Emeritus.  Prior …

Robert Shepler Read More »